Literature DB >> 12088511

Gastrointestinal effects of prebiotics.

J H Cummings1, G T Macfarlane.   

Abstract

The defining effect of prebiotics is to stimulate selectively the growth of bifidobacteria and lactobacilli in the gut and, thereby, increase the body's natural resistance to invading pathogens. Prebiotic carbohydrates may also have additional, less specific, benefits because they are fermented in the large intestine. The prebiotic carbohydrates that have been evaluated in humans at the present time largely consist of fructans or galactans. There is consistent evidence from in vitro and in vivo studies that these are not digested by normal human enzymes, but are readily fermented by anaerobic bacteria in the large intestine. There are no reports of faecal recovery of measurable quantities of prebiotic carbohydrates. Through fermentation in the large intestine, prebiotic carbohydrates yield short-chain fatty acids, stimulate the growth of many bacterial species in addition to the selective effects on lactobacilli and bifidobacteria, they can also produce gas. Along with other fermented carbohydrates, prebiotics have mild laxative effects, although this has proved difficult to demonstrate in human studies because the magnitude of laxation is small. Potentially, the most important effect of prebiotic carbohydrates is to strengthen the body's resistance to invading pathogens and, thereby, prevent episodes of diarrhoea. At the present time, this effect has not been convincingly demonstrated in either adults or children, although there have been attempts to ameliorate the diarrhoea associated with antibiotics and travel, but without success. However, prebiotic carbohydrates clearly have significant and distinctive physiological effects in the human large intestine, and on the basis of this it is likely that they will ultimately be shown to be beneficial to health.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088511     DOI: 10.1079/BJNBJN/2002530

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  45 in total

1.  Prebiotics for the prevention of hyperbilirubinaemia in neonates.

Authors:  Amir Mohammad Armanian; Shayesteh Jahanfar; Awat Feizi; Nima Salehimehr; Mitra Molaeinezhad; Erfan Sadeghi
Journal:  Cochrane Database Syst Rev       Date:  2019-08-13

2.  The Effects of a Synbiotic Mixture of Galacto-Oligosaccharides and Bacillus Strains in Caspian Salmon, Salmo trutta caspius Fingerlings.

Authors:  Maryam Aftabgard; Alireza Salarzadeh; Mahmoud Mohseni
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

3.  Butyrate stimulates IL-32alpha expression in human intestinal epithelial cell lines.

Authors:  Ayako Kobori; Shigeki Bamba; Hirotsugu Imaeda; Hiromitsu Ban; Tomoyuki Tsujikawa; Yasuharu Saito; Yoshihide Fujiyama; Akira Andoh
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

4.  Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease.

Authors:  Irit Chermesh; Ada Tamir; Ron Reshef; Yehuda Chowers; Alain Suissa; Dalia Katz; Moshe Gelber; Zamir Halpern; Stig Bengmark; Rami Eliakim
Journal:  Dig Dis Sci       Date:  2007-01-09       Impact factor: 3.199

Review 5.  Microbiota-based treatments in alcoholic liver disease.

Authors:  Hotaik Sung; Seung Woo Kim; Meegun Hong; Ki Tae Suk
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

Review 6.  The Current Status of the Alternative Use to Antibiotics in Poultry Production: An African Perspective.

Authors:  Letlhogonolo Andrew Selaledi; Zahra Mohammed Hassan; Tlou Grace Manyelo; Monnye Mabelebele
Journal:  Antibiotics (Basel)       Date:  2020-09-11

7.  Specific response of a novel and abundant Lactobacillus amylovorus-like phylotype to dietary prebiotics in the guts of weaning piglets.

Authors:  Sergey R Konstantinov; Ajay Awati; Hauke Smidt; Barbara A Williams; Antoon D L Akkermans; Willem M de Vos
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

8.  Effect of a new synbiotic supplement on symptoms, stool consistency, intestinal transit time and gut microbiota in patients with severe functional constipation: a pilot randomized double-blind, controlled trial.

Authors:  G Bazzocchi; T Giovannini; C Giussani; P Brigidi; S Turroni
Journal:  Tech Coloproctol       Date:  2014-08-05       Impact factor: 3.781

9.  Cellobiose Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis.

Authors:  Takashi Nishimura; Akira Andoh; Takayoshi Hashimoto; Ayako Kobori; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  J Clin Biochem Nutr       Date:  2010-02-24       Impact factor: 3.114

Review 10.  Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings.

Authors:  Lay-Gaik Ooi; Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2010-06-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.